165 related articles for article (PubMed ID: 18157394)
61. Localization of ectopic parathyroid glands using technetium-99m sestamibi imaging: comparison with magnetic resonance and computed tomographic imaging.
Ishibashi M; Nishida H; Hiromatsu Y; Kojima K; Uchida M; Hayabuchi N
Eur J Nucl Med; 1997 Feb; 24(2):197-201. PubMed ID: 9021118
[TBL] [Abstract][Full Text] [Related]
62. Impact of technetium-99m-sestamibi localization on operative time and success of operations for primary hyperparathyroidism.
Casas AT; Burke GJ; Mansberger AR; Wei JP
Am Surg; 1994 Jan; 60(1):12-6; discussion 16-7. PubMed ID: 8273968
[TBL] [Abstract][Full Text] [Related]
63. Hyperparathyroidism in high-risk surgical patients: evaluation with double-phase technetium-99m sestamibi imaging.
Lee VS; Wilkinson RH; Leight GS; Coogan AC; Coleman RE
Radiology; 1995 Dec; 197(3):627-33. PubMed ID: 7480730
[TBL] [Abstract][Full Text] [Related]
64. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
Hatada K; Riou LM; Ruiz M; Yamamichi Y; Duatti A; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK
J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487
[TBL] [Abstract][Full Text] [Related]
65. The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging.
Johnston LB; Carroll MJ; Britton KE; Lowe DG; Shand W; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1996 Jan; 81(1):346-52. PubMed ID: 8550776
[TBL] [Abstract][Full Text] [Related]
66. [99m Tc-sestamibi in the diagnosis of the location of hyperparathyroidism].
Berná Roqueta L
Rev Esp Med Nucl; 1998; 17(2):102-11. PubMed ID: 9611280
[No Abstract] [Full Text] [Related]
67. Parathyroid scintigraphy.
Prekeges JL; Eisenberg B
J Nucl Med Technol; 1997 Mar; 25(1):59-65. PubMed ID: 9239607
[TBL] [Abstract][Full Text] [Related]
68. Nuclear Medicine Methods for Evaluation of Abnormal Parathyroid Glands in Patients with Primary and Secondary Hyperparathyroidism.
Botushanova AD; Botushanov NP; Yaneva MP
Folia Med (Plovdiv); 2017 Dec; 59(4):396-404. PubMed ID: 29341944
[TBL] [Abstract][Full Text] [Related]
69. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M
J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
[TBL] [Abstract][Full Text] [Related]
70. 99Tcm sestamibi--a new agent for parathyroid imaging.
Coakley AJ; Kettle AG; Wells CP; O'Doherty MJ; Collins RE
Nucl Med Commun; 1989 Nov; 10(11):791-4. PubMed ID: 2532313
[TBL] [Abstract][Full Text] [Related]
71. (99m)Tc-sestamibi scintigraphy and cell cycle in parathyroid glands of secondary hyperparathyroidism.
Torregrosa JV; Fernández-Cruz L; Canalejo A; Vidal S; Astudillo E; Almaden Y; Pons F; Rodriguez M
World J Surg; 2000 Nov; 24(11):1386-90. PubMed ID: 11038211
[TBL] [Abstract][Full Text] [Related]
72. Comparison of histological findings and parathyroid scintigraphy in hemodialysis patients with secondary hyperparathyroid glands.
Nishida H; Ishibashi M; Hiromatsu Y; Kaida H; Baba K; Miyake I; Ikedo H; Kato S; Fukami K; Iida S; Okuda S
Endocr J; 2005 Apr; 52(2):223-8. PubMed ID: 15863952
[TBL] [Abstract][Full Text] [Related]
73. Tc-99m tetrofosmin in breast carcinoma and axillary lymph node metastases: a comparative study with Tc-99m MIBI.
Akçay MN; Akin Y; Karabağ B; Ozcan O; Oren D
Clin Nucl Med; 1997 Dec; 22(12):832-4. PubMed ID: 9408644
[TBL] [Abstract][Full Text] [Related]
74. Parathyroid imaging: the importance of pinhole collimation with both single- and dual-tracer acquisition.
Klingensmith WC; Koo PJ; Summerlin A; Fehrenbach BW; Karki R; Shulman BC; Raeburn CD; McIntyre RC
J Nucl Med Technol; 2013 Jun; 41(2):99-104. PubMed ID: 23539762
[TBL] [Abstract][Full Text] [Related]
75. Technetium-99m tetrofosmin imaging in thyroid diseases: comparison with Tc-99m-pertechnetate, thallium-201 and Tc-99m-methoxyisobutylisonitrile scans.
Klain M; Maurea S; Cuocolo A; Colao A; Marzano L; Lombardi G; Salvatore M
Eur J Nucl Med; 1996 Dec; 23(12):1568-74. PubMed ID: 8929309
[TBL] [Abstract][Full Text] [Related]
76. The effect of imaging time, radiopharmaceutical, full fat milk and water on interfering extra-cardiac activity in myocardial perfusion single photon emission computed tomography.
Peace RA; Lloyd JJ
Nucl Med Commun; 2005 Jan; 26(1):17-24. PubMed ID: 15604943
[TBL] [Abstract][Full Text] [Related]
77. A comparison of Tl-201, Tc-99m sestamibi, and Tc-99m tetrofosmin myocardial perfusion scintigraphy in patients with mild to moderate coronary stenosis.
Reyes E; Loong CY; Harbinson M; Rahman S; Prvulovich E; Ell PJ; Anagnostopoulos C; Underwood SR
J Nucl Cardiol; 2006 Jul; 13(4):488-94. PubMed ID: 16919572
[TBL] [Abstract][Full Text] [Related]
78. Preliminary experience with double-phase SPECT using Tc-99m sestamibi in patients with hyperparathyroidism.
Neumann DR; Esselstyn CB; Kim EY; Go RT; Obuchowski NA; Rice TW
Clin Nucl Med; 1997 Apr; 22(4):217-21. PubMed ID: 9099475
[TBL] [Abstract][Full Text] [Related]
79. Dual-phase 99mTc-sestamibi imaging: its utility in parathyroid hyperplasia and use of immediate/delayed image ratios to improve diagnosis of hyperparathyroidism.
Gordon L; Burkhalter W; Mah E
J Nucl Med Technol; 2002 Dec; 30(4):179-84. PubMed ID: 12446751
[TBL] [Abstract][Full Text] [Related]
80. Relation between technetium 99m-methoxyisobutylisonitrile accumulation and multidrug resistance protein in the parathyroid glands.
Yamaguchi S; Yachiku S; Hashimoto H; Kaneko S; Nishihara M; Niibori D; Shuke N; Aburano T
World J Surg; 2002 Jan; 26(1):29-34. PubMed ID: 11898030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
